Podcast Episode 52 | The Hierarchical Taxonomy of Psychopathology (HiTOP) – With Dr. Robert Latzman
Our current nosology of psychopathology relies on a categorical model that has notable limitations. For example, this medical model of classifying mental disorders does not account for the significant heterogeneity of symptom presentations across psychopathology. Today, we speak with Robert Latzman, Ph.D., to discuss the Hierarchical Taxonomy of Psychopathology (HiTOP), an alternative nosology that uses […]
Podcast Episode 63 | COVID-19: The Role of Neuropsychology – With Dr. Chaya Fridman
Emerging research suggests that a sizeable portion of individuals hospitalized due to COVID-19 develop cognitive and psychological sequelae. In our conversation with Dr. Chaya Fridman, a board-certified neuropsychologist at Cornell, we discuss the ways that SARS-CoV-2 (the virus that causes COVID-19) may lead to neurocognitive impairment, including both direct effects of the virus and secondary […]
Podcast Episode 62 | Multiple Sclerosis: Cognitive and Emotional Sequelae – with Dr. Peter Arnett
About 50% of individuals with multiple sclerosis (MS) exhibit cognitive deficits in additional to physical symptoms. Depression and fatigue are also common in MS and can be debilitating. Therefore, it is not uncommon for an individual with MS to be referred for neuropsychological evaluation, making it important for neuropsychologists to familiarize themselves with the neurobiological […]
Podcast Episode 20 | The Interplay Between Cerebrovascular Disease and Alzheimer’s Disease – With Dr. Adam Brickman
Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation. Dr. Brickman discusses his research on the presence of biomarkers of cerebrovascular disease (e.g., white matter hyperintensities), which are present in aging and Alzheimer’s disease. Although cerebrovascular disease is traditionally associated with its own unique cognitive […]
Podcast Episode 19 | Redefining Alzheimer’s Disease: Does Cognition Matter? – With Dr. Adam Brickman
The estimated annual cost of healthcare for individuals living with Alzheimer’s disease (AD) or other dementias is almost $300 billion. In addition to this financial burden, the number of adults aged 65 or older is projected to double and it is expected an estimated 10 million of these individuals will develop AD by 2050. Despite […]
Podcast Episode 33 | Neuropsychology 3.0 – With Dr. Robert Bilder
Research has repeatedly demonstrated the benefits of neuropsychological evaluations to patients and their families. However, there is great potential for advancement and improvement in the field. For example, there is growing interest in improving the validity of neuropsychological tests in the assessment and prediction of complex medical conditions using biological, statistical, and informatic techniques. We […]
Podcast Episode 30 | The NIH Toolbox – With Dr. Julie Hook
Dr. Hook is a Research Associate Professor in the Department of Medical Social Sciences at the Northwestern University Feinberg School of Medicine, and is Product Manager of the NIH Toolbox®. She participates in grant funded research and directs the marketing efforts and strategic direction for the NIH Toolbox. Her interests in test development and combining […]
Podcast Episode 27 | Pediatric Traumatic Brain Injury – With Dr. Keith Yeates
We discussed INS leadership and research productivity with Keith Yeates, Ph.D., ABPP-CN, in a previous episode. As the most published investigator of pediatric traumatic brain injury (TBI) in the world over the last 10 years, he returns today to discuss the prevalence rates and causes, behavioral sequalae, differences in outcomes, and psychosocial interventions for children […]
Podcast Episode 40 | The Effect of Opioid Use and Treatment on Cognition With Dr. Monica Rivera Mindt
We brought Monica Rivera Mindt, Ph.D., ABPP-CN, back on the podcast to discuss the cognitive effects of opioid use (both licit and illicit). We discuss the history of the opioid epidemic in the U.S., the neurobiology of opioids, and common treatments for opioid use disorder.
Podcast Episode 18 | Fetal Alcohol Spectrum Disorder – With Dr. Jeffrey Wozniak
Today we give an overview of Fetal Alcohol Spectrum Disorder (FASD), which includes a collection of disorders that occur when a fetus is exposed to alcohol. We discuss this topic with Jeffrey Wozniak, Ph.D., a neuropsychologist with extensive research and clinical experience in FASD.